DAVOS: In Pharma, Europe Is Slipping Behind, With China Gaining, Sanofi CEO Says -- Market Talk

Dow Jones01-21

1116 GMT - Europe is slipping behind in the pharmaceutical industry, while China makes progress, Sanofi CEO Paul Hudson says in Davos. "For the first time, China and the U.S. publish more clinical papers, win more Nobel prizes and discover more medicines than Europe, and Europe is slipping behind," Hudson says at the World Economic Forum in Davos. "I think China is coming. China is going to launch 40% of the world's new medicines by 2030, 40%, and we're not having that conversation." Europe has all of the skills and capabilities to compete with China and the U.S. in the rest of the world if this is prioritized, but European policymakers seem more focused on "fair play" between member states than on competing with other powers, he says. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

January 21, 2026 06:16 ET (11:16 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605106523?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-21 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605106523","market":"sh","top_or_hot":-1,"title":"DAVOS: In Pharma, Europe Is Slipping Behind, With China Gaining, Sanofi CEO Says -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1116 GMT - Europe is slipping behind in the pharmaceutical industry, while China makes progress, <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> CEO Paul Hudson says in Davos. \"For the first time, China and the U.S. publish more clinical papers, win more Nobel prizes and discover more medicines than Europe, and Europe is slipping behind,\" Hudson says at the World Economic Forum in Davos. \"I think China is coming. China is going to launch 40% of the world's new medicines by 2030, 40%, and we're not having that conversation.\" Europe has all of the skills and capabilities to compete with China and the U.S. in the rest of the world if this is prioritized, but European policymakers seem more focused on \"fair play\" between member states than on competing with other powers, he says. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 21, 2026 06:16 ET (11:16 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DAVOS: In Pharma, Europe Is Slipping Behind, With China Gaining, Sanofi CEO Says -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDAVOS: In Pharma, Europe Is Slipping Behind, With China Gaining, Sanofi CEO Says -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-21 19:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1116 GMT - Europe is slipping behind in the pharmaceutical industry, while China makes progress, <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> CEO Paul Hudson says in Davos. \"For the first time, China and the U.S. publish more clinical papers, win more Nobel prizes and discover more medicines than Europe, and Europe is slipping behind,\" Hudson says at the World Economic Forum in Davos. \"I think China is coming. China is going to launch 40% of the world's new medicines by 2030, 40%, and we're not having that conversation.\" Europe has all of the skills and capabilities to compete with China and the U.S. in the rest of the world if this is prioritized, but European policymakers seem more focused on \"fair play\" between member states than on competing with other powers, he says. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 21, 2026 06:16 ET (11:16 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2605106523","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605106523","pubTimestamp":1768994160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1116 GMT - Europe is slipping behind in the pharmaceutical industry, while China makes progress, Sanofi CEO Paul Hudson says in Davos. \"For the first time, China and the U.S. publish more clinical papers, win more Nobel prizes and discover more medicines than Europe, and Europe is slipping behind,\" Hudson says at the World Economic Forum in Davos. \"I think China is coming. China is going to launch 40% of the world's new medicines by 2030, 40%, and we're not having that conversation.\" Europe has all of the skills and capabilities to compete with China and the U.S. in the rest of the world if this is prioritized, but European policymakers seem more focused on \"fair play\" between member states than on competing with other powers, he says. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","SNYNF":"Sanofi","SNY":"赛诺菲安万特","BK4585":"ETF&股票定投概念","BK4007":"制药","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC"},"translate_title":"达沃斯：赛诺菲首席执行官表示，在制药领域，欧洲正在落后，而中国正在崛起——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNY":0.9,"SNYNF":1.5},"content_text":"1116 GMT - Europe is slipping behind in the pharmaceutical industry, while China makes progress, Sanofi CEO Paul Hudson says in Davos. \"For the first time, China and the U.S. publish more clinical papers, win more Nobel prizes and discover more medicines than Europe, and Europe is slipping behind,\" Hudson says at the World Economic Forum in Davos. \"I think China is coming. China is going to launch 40% of the world's new medicines by 2030, 40%, and we're not having that conversation.\" Europe has all of the skills and capabilities to compete with China and the U.S. in the rest of the world if this is prioritized, but European policymakers seem more focused on \"fair play\" between member states than on competing with other powers, he says. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2026 06:16 ET (11:16 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605106523","isCrawlerRequest":true}